Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-022062)

Filing Details

Accession Number:: 0001209191-19-022062
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-04-01 18:14:45
Reporting Period:: 2019-03-29

Accepted Time:: 2019-04-01 18:14:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
831547	Spectrum Pharmaceuticals Inc	SPPI	Pharmaceutical Preparations (2834)	930979187

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1462354	A Kurt Gustafson	11500 S. Eastern Ave. Suite 240 Henderson NV 89052	Evp & Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001	Disposition	2019-03-29	5,974	$10.65	240,740	No	4	S	Direct
Common Stock, $0.001	Disposition	2019-04-01	1,642	$10.81	239,098	No	4	S	Direct
Common Stock, $0.001	Disposition	2019-04-01	3,000	$10.73	236,098	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001	7,758	Indirect	By 401(k) Plan

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
The shares were sold in this transaction by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.